Why do we need noncommercial, investigator-initiated clinical trials?

被引：0
|
作者：
Alan Tyndall
机构：
[1] University of Basel,A Tyndall is Professor and Head of the Department of Rheumatology
[2] Switzerland.,undefined
来源：
Nature Clinical Practice Rheumatology | 2008年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Noncommercial, investigator-initiated trials are an essential part of clinical research. In this Viewpoint, the author describes the burden of current legislation on investigator-initiated trials and explores possible solutions.
引用
收藏
页码：354 / 355
页数：1
相关论文
共 50 条
  • [21] Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN)
    Madeira, C.
    Pais, A.
    Kubiak, C.
    Demotes, J.
    Monteiro, E. C.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2016, 4 : 141 - 148
  • [22] International models of investigator-initiated trials: implications for Japan
    Trimble, E. L.
    Ledermann, J.
    Law, K.
    Miyata, T.
    Imamura, C. K.
    Nam, B. -H.
    Kim, Y. H.
    Bang, Y. -J.
    Michaels, M.
    Ardron, D.
    Amano, S.
    Ando, Y.
    Tominaga, T.
    Kurokawa, K.
    Takebe, N.
    ANNALS OF ONCOLOGY, 2012, 23 (12) : 3151 - 3155
  • [23] The development and challenges of Investigator-Initiated Trials (IITs) in China
    Minghuang Hong
    Zhao Yan
    Holistic Integrative Oncology, 3 (1):
  • [24] Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
    Yaegashi, Hiroko
    Hayashi, Yukikazu
    Takeda, Makoto
    Chiu, Shih-Wei
    Nakayama, Haruhiko
    Ito, Hiroyuki
    Takano, Atsushi
    Tsuboi, Masahiro
    Teramoto, Koji
    Suzuki, Hiroyuki
    Kato, Tatsuya
    Yasui, Hiroshi
    Nagamura, Fumitaka
    Daigo, Yataro
    Yamaguchi, Takuhiro
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (06) : 1031 - 1041
  • [25] Investigator-initiated Clinical Trials for Neurological Diseases in Japan: Pipeline and Support Structures
    Sakushima, Ken
    Nakamura, Harumasa
    Fujihara, Kazuo
    NEUROTHERAPEUTICS, 2024, 21 (04)
  • [26] Mobile access to virtual randomization for investigator-initiated trials
    Deserno, Thomas M.
    Keszei, Andras P.
    CLINICAL TRIALS, 2017, 14 (04) : 396 - 405
  • [27] Investigator-initiated cancer trials with INDs for approval in Japan
    Chiyo K. Imamura
    Naoko Takebe
    Seigo Nakamura
    Hideyuki Saya
    Naoto T. Ueno
    Nature Reviews Clinical Oncology, 2010, 7 : 127 - 128
  • [28] NIH MULTICENTER INVESTIGATOR-INITIATED TRIALS - AN ENDANGERED SPECIES
    MEINERT, CL
    CONTROLLED CLINICAL TRIALS, 1988, 9 (02): : 97 - 102
  • [29] Lessons learned from investigator-initiated clinical trials for localized pancreatic cancer
    Tsai, Susan
    Evans, Douglas B.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (01) : 69 - 74
  • [30] Randomized clinical trials in surgery: Why do we need them?
    Balch, Charles M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 132 (02): : 241 - 242
12345